Analyst Ratings for Immune Design (IMDZ)

IMDZ Rating Summary

  |   Expand Research on IMDZ
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/22/2019 RBC Capital Brian Abrahams Downgrade Sector Perform
(Outperform)		 6.00
(9.00)		 5.82
(5.85)		 0.52% Details
2/21/2019 H.C. Wainwright Joseph Pantginis Downgrade Neutral
(Buy)		 N/A
(N/A)		 1.42
(5.85)		 311.97% Details